David-Alexandre Gros is the founder of Novus Therapeutics. Novus Therapeutics has raised $108M in total funding. Latest round: Growth.
David-Alexandre Gros is listed on LinkedIn as Chief Executive Officer and Director of Eledon Pharmaceuticals, and as Executive Chairman of Saint Jean Groupe. Eledon Pharmaceuticals was formerly Novus Therapeutics, which announced a name change to Eledon in January 2021. Public sources in the provided results do not show a Novus Therapeutics-specific founder bio or a direct confirmation that Gros was a founder of Novus Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library